FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039771346> ?p ?o ?g. }

• W3039771346 endingPage "2272" @default.
• W3039771346 startingPage "2266" @default.
• W3039771346 abstract "The present study aimed to investigate the clinical characteristics and outcomes of patients with advanced non-small cell lung cancer (NSCLC) treated with osimertinib, and focused on the resistance mechanism to osimertinib in a real-world setting. Data from 128 patients with advanced NSCLC who were treated with osimertinib between March 2015 and November 2018 at the Chinese People's Liberation Army General Hospital (Beijing, China) were retrospectively collected, and the associations between mutation types and survival were analysed. In patients treated with osimertinib, the objective response rate reached 60.9% (78/128) and the disease control rate reached 81.3% (104/128), with a median progression-free survival (PFS) time of 12.2 months. A number of complex mutations were identified in the re-analysis after the development of osimertinib resistance, including TP53, KRAS and PIK3CA mutations, epidermal growth factor receptor (EGFR) and MYC amplifications, and mutations associated with SCLC transformation, demonstrating that these mutations may account for osimertinib resistance. The median PFS time for patients with the EGFR T790M mutation (n=41) was significantly longer than that for patients with the T790M mutation and the aforementioned complex mutations (n=13) (16.7 vs. 10.8 months; P=0.001). Patients with a single EGFR mutation (n=87) had a longer median PFS time than those with an EGFR mutation and complex mutations (n=24) (14.63 vs. 6.63 months; P<0.0001). In conclusion, the present study analysed the effects of osimertinib in patients with advanced NSCLC with EGFR mutations, particularly T790M mutations. The results indicated that the efficacy of osimertinib was weakened when patients had complex mutations, suggesting that complex mutations may be responsible for resistance to osimertinib." @default.
• W3039771346 created "2020-07-10" @default.
• W3039771346 creator A5040300236 @default.
• W3039771346 creator A5041284796 @default.
• W3039771346 creator A5053503409 @default.
• W3039771346 creator A5055770655 @default.
• W3039771346 creator A5067865085 @default.
• W3039771346 date "2020-07-01" @default.
• W3039771346 modified "2023-10-01" @default.
• W3039771346 title "Patients with advanced non‑small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real‑world data analysis" @default.
• W3039771346 cites W1546552389 @default.
• W3039771346 cites W1904060183 @default.
• W3039771346 cites W1908940658 @default.
• W3039771346 cites W1968064103 @default.
• W3039771346 cites W1980497534 @default.
• W3039771346 cites W2014993624 @default.
• W3039771346 cites W2019607817 @default.
• W3039771346 cites W2040575339 @default.
• W3039771346 cites W2050211354 @default.
• W3039771346 cites W2058822154 @default.
• W3039771346 cites W2065293650 @default.
• W3039771346 cites W2108125678 @default.
• W3039771346 cites W2139236349 @default.
• W3039771346 cites W2154149901 @default.
• W3039771346 cites W2161821474 @default.
• W3039771346 cites W2256274387 @default.
• W3039771346 cites W2336204264 @default.
• W3039771346 cites W2400274474 @default.
• W3039771346 cites W2462969936 @default.
• W3039771346 cites W2465575913 @default.
• W3039771346 cites W2472419401 @default.
• W3039771346 cites W2530508394 @default.
• W3039771346 cites W2559746652 @default.
• W3039771346 cites W2566097899 @default.
• W3039771346 cites W2595645511 @default.
• W3039771346 cites W2605556058 @default.
• W3039771346 cites W2605806843 @default.
• W3039771346 cites W2611868247 @default.
• W3039771346 cites W2615043197 @default.
• W3039771346 cites W2655216406 @default.
• W3039771346 cites W2769241338 @default.
• W3039771346 cites W2770828094 @default.
• W3039771346 cites W2781759361 @default.
• W3039771346 cites W2783363324 @default.
• W3039771346 cites W2789842110 @default.
• W3039771346 cites W2808137450 @default.
• W3039771346 cites W2809219312 @default.
• W3039771346 cites W2890155867 @default.
• W3039771346 cites W2895350217 @default.
• W3039771346 cites W2903120675 @default.
• W3039771346 cites W2904243123 @default.
• W3039771346 cites W2917696006 @default.
• W3039771346 cites W2922022182 @default.
• W3039771346 doi "https://doi.org/10.3892/ol.2020.11801" @default.
• W3039771346 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7399948" @default.
• W3039771346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32782544" @default.
• W3039771346 hasPublicationYear "2020" @default.
• W3039771346 type Work @default.
• W3039771346 sameAs 3039771346 @default.
• W3039771346 citedByCount "6" @default.
• W3039771346 countsByYear W30397713462021 @default.
• W3039771346 countsByYear W30397713462022 @default.
• W3039771346 countsByYear W30397713462023 @default.
• W3039771346 crossrefType "journal-article" @default.
• W3039771346 hasAuthorship W3039771346A5040300236 @default.
• W3039771346 hasAuthorship W3039771346A5041284796 @default.
• W3039771346 hasAuthorship W3039771346A5053503409 @default.
• W3039771346 hasAuthorship W3039771346A5055770655 @default.
• W3039771346 hasAuthorship W3039771346A5067865085 @default.
• W3039771346 hasBestOaLocation W30397713461 @default.
• W3039771346 hasConcept C104317684 @default.
• W3039771346 hasConcept C121608353 @default.
• W3039771346 hasConcept C126322002 @default.
• W3039771346 hasConcept C143998085 @default.
• W3039771346 hasConcept C2776256026 @default.
• W3039771346 hasConcept C2777626846 @default.
• W3039771346 hasConcept C2777930144 @default.
• W3039771346 hasConcept C2778087573 @default.
• W3039771346 hasConcept C2779438470 @default.
• W3039771346 hasConcept C2780580887 @default.
• W3039771346 hasConcept C2781187634 @default.
• W3039771346 hasConcept C501734568 @default.
• W3039771346 hasConcept C502942594 @default.
• W3039771346 hasConcept C526805850 @default.
• W3039771346 hasConcept C54355233 @default.
• W3039771346 hasConcept C71924100 @default.
• W3039771346 hasConcept C86803240 @default.
• W3039771346 hasConceptScore W3039771346C104317684 @default.
• W3039771346 hasConceptScore W3039771346C121608353 @default.
• W3039771346 hasConceptScore W3039771346C126322002 @default.
• W3039771346 hasConceptScore W3039771346C143998085 @default.
• W3039771346 hasConceptScore W3039771346C2776256026 @default.
• W3039771346 hasConceptScore W3039771346C2777626846 @default.
• W3039771346 hasConceptScore W3039771346C2777930144 @default.
• W3039771346 hasConceptScore W3039771346C2778087573 @default.
• W3039771346 hasConceptScore W3039771346C2779438470 @default.
• W3039771346 hasConceptScore W3039771346C2780580887 @default.
• W3039771346 hasConceptScore W3039771346C2781187634 @default.

• next